Skip to main content
Premium Trial:

Request an Annual Quote

Pressure Biosciences Names German Distributor for Sample Prep Products

Premium

Pressure Biosciences said today that it has entered into a distribution agreement with Königswinter, Germany-based IUL Instruments.

Under the agreement, IUL will exclusively market and sell PBI's pressure cycling technology sample preparation instruments – the Barocycler NEP2320 and NEP3229 – and associated consumables in Germany and Switzerland.

In addition, IUL will non-exclusively market and sell PBI's recently released mechanical homogenization device, the Shredder SG3, and associated consumables, in the same countries.

PBI's pressure cycling technology, or PCT, uses cycles of hydrostatic pressure to control biomolecular interactions. Its PCT-enhanced sample preparation systems are used for mass spectrometry, biomarker discovery, biotherapeutic characterization, vaccine development, soil and plant biology, forensics, histology, and defense applications.

The Shredder SG3 is a mechanical homogenization system that rapidly homogenizes tough, fibrous, and other difficult-to-disrupt tissues and organisms directly in a pulse tube. This pre-processing method increases sample surface area and, when followed by PCT extraction, permits better access of high-pressure extraction fluid to the sample, resulting in improved sample lysis and extraction of the desired analytes, PBI said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.